FDA.reportPublic FDA data

NDC 86004-100 - Animalgesics for Mice

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
86004-100
Package NDCs from labels
86004-100-30
Manufacturer
ANIMALGESIC LABORATORIES, INC. | Noramco, Inc.
Effective date
2014-02-07
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Animalgesics for MiceANIMALGESIC LABORATORIES, INC. | Noramco, Inc.2014-02-07PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BUPRENORPHINE HYDROCHLORIDEACTIVE INGREDIENT56W8MW3EN1ANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1
BUPRENORPHINEACTIVE MOIETY40D3SCR4GZANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1
CAPRYLIC/CAPRIC/LAURIC TRIGLYCERIDEINACTIVE INGREDIENTFJ1H6M2JG9ANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1
CHOLESTEROLINACTIVE INGREDIENT97C5T2UQ7JANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1
TRISTEARININACTIVE INGREDIENTP6OCJ2551RANIMALGESICS FOR MICE (BUPRENORPHINE HYDROCHLORIDE) INJECTION, SUSPENSION, EXTENDED RELEASE [ANIMALGESIC LABORATORIES, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 9 · 169 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONEActavis Pharma, Inc.6cccf229-9611-4b6f-8f1b-acc8ff1ed3f82026-02-06Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine HCl and Naloxone HClBUPRENORPHINE AND NALOXONEAmneal Pharmaceuticals LLC17b63f10-c9df-44be-80fa-6f1c305583b82026-02-02Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONECamber Pharmaceuticals, Inc.221195e4-de08-414c-af08-a611a74789de2026-01-30Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Varicose VeinsELAPS CORALLINUS, CROTALUS HORRIDUS, BRYONIA, CALC. FLUOR., CARDUUS MAR., CHOLESTERINUM, CINCHONA, DIGITALIS, HAMAMELIS, HYDROFLUORICUM ACIDUM, LACHESIS, LYCOPODIUM, NAJA, PULSATILLA, VIPERA BERUS, ZINC. MET., AESCULUS HIPP., ECHINACEANewton Laboratories, Inc.91e8e37c-c654-6df9-e053-2995a90aafe12026-01-29WarningsExact identifier
unii: 97C5T2UQ7J
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONECamber Pharmaceuticals, Inc.5ab2d4e4-3c8c-413a-b147-23eafbde313a2026-01-28Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
BuprenorphineBUPRENORPHINEHikma Pharmaceuticals USA Inc.1bf8b35a-b769-465c-a2f8-099868dfcd2f2026-01-24Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATEBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATERedpharm Drug44f2e26f-4586-5204-e063-6394a90a47d52026-01-23Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine HClBUPRENORPHINE HCLCamber Pharmaceuticals, Inc.b52cea0e-688f-4beb-bf7d-f228b81dbd232026-01-23Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONEMylan Pharmaceuticals Inc.557d8d4d-8751-431c-b18e-9d5cf23fc5792026-01-15Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONEDr.Reddys Laboratories Inc718756d7-0131-b173-6c45-5ee039b311b02026-01-12Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine and NaloxoneBUPRENORPHINE AND NALOXONEDr.Reddys Laboratories Inc72dc1ec0-7c59-a587-4ffd-c40ef79e6fb22026-01-12Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Vascu-Pro T009CACTUS GRANDIFLORUS, HAMAMELIS VIRGINIANA, VALERIANA OFFICINALIS, ARTERIA SUIS, HEART (SUIS), ARNICA MONTANA, AURUM METALLICUM, BARYTA MURIATICA, CHOLESTERINUM, LECITHIN, MAGNESIA MURIATICA, OXALICUM ACIDUM, PHOSPHORUSGuangzhou Renuma Medical Systems Co., Ltd01d22fd6-7d2f-4448-81ff-c88baafc0af72026-01-09WarningsExact identifier
unii: 97C5T2UQ7J
Gallbladder Drops 5006GALLBLADDER DROPSProfessional Complementary Health Formulasf07b10e1-00b1-47d7-b745-72165781c6d22026-01-08WarningsExact identifier
unii: 97C5T2UQ7J
BuprenorphineBUPRENORPHINEAvPAK1408cd8f-a0b5-6be7-e063-6394a90a0b412026-01-08Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Buprenorphine HCl and Naloxone HClBUPRENORPHINE AND NALOXONEAvPAKb955054b-b37d-4079-4fed-5939b763ecb42026-01-08Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Anti-Constipation Drops 2077ANTI-CONSTIPATION DROPSProfessional Complementary Health Formulas55d105fe-5698-43a6-9252-eaa9b63299d02026-01-08WarningsExact identifier
unii: 97C5T2UQ7J
POP Detox 6045POP DETOXProfessional Complementary Health Formulas48e7e23a-014c-4259-a2c9-37127da3ba032026-01-08WarningsExact identifier
unii: 97C5T2UQ7J
Blood Clenz Drops 2012BLOOD CLENZ DROPSProfessional Complementary Health Formulas80a273da-bce5-4e37-89da-f40db0491e622026-01-08WarningsExact identifier
unii: 97C5T2UQ7J
Cholesterol 1551CHOLESTEROLProfessional Complementary Health Formulasc8f91020-5840-4e8f-a7ab-867c7e11fb632026-01-08WarningsExact identifier
unii: 97C5T2UQ7J
Carduus Combination 9215CARDUUS COMBINATIONProfessional Complementary Health Formulasa244de13-836f-49b5-8c7a-d45bde704d782026-01-08WarningsExact identifier
unii: 97C5T2UQ7J

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.